Unicycive Therapeutics, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
UNCY on Nasdaq
Industry
Pharmaceutical Preparations
Location
4300 El Camino Real, Suite 210, Los Altos, CA

There are no Buy or Sell transactions made by insiders since 9/14/2023

Unicycive Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gaurav Aggarwal Director Sep 5, 2023
Shalabh Gupta CEO, Director Aug 12, 2024
Pramod Gupta EVP, Pharmaceuticals and BD Aug 12, 2024
Brigitte Schiller Director Jul 15, 2022
John Ryan Director Sep 5, 2023
Sara Kenkare-Mitra Director Sep 5, 2023
John Townsend Chief Financial Officer Aug 12, 2024
Douglas Jermasek EVP of Corporate Strategy Aug 12, 2024
Sandeep Laumas Director Sep 5, 2023

Recent Insider Transactions by Companies or Individuals for Unicycive Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.